Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Ligands of the peripheral benzodiazepine receptor are potent inhibitors of Plasmodium falciparum and Toxoplasma gondii in vitro.

Dzierszinski F, Coppin A, Mortuaire M, Dewailly E, Slomianny C, Ameisen JC, DeBels F, Tomavo S.

Antimicrob Agents Chemother. 2002 Oct;46(10):3197-207.

2.

Potent antimalarial activity of clotrimazole in in vitro cultures of Plasmodium falciparum.

Tiffert T, Ginsburg H, Krugliak M, Elford BC, Lew VL.

Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):331-6.

3.

Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.

Guiguemde WA, Hunt NH, Guo J, Marciano A, Haynes RK, Clark J, Guy RK, Golenser J.

Antimicrob Agents Chemother. 2014 Aug;58(8):4745-54. doi: 10.1128/AAC.01553-13. Epub 2014 Jun 9.

4.

[In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].

Touré AO, Koné LP, Jambou R, Konan TD, Demba S, Beugre GE, Koné M.

Sante. 2008 Jan-Mar;18(1):43-7. doi: 10.1684/san.2008.0103. French.

5.

Declining chloroquine resistance of Plasmodium falciparum in Lambaréné, Gabon from 1992 to 1998.

Schwenke A, Brandts C, Philipps J, Winkler S, Wernsdorfer WH, Kremsner PG.

Wien Klin Wochenschr. 2001 Jan 15;113(1-2):63-4.

PMID:
11233471
6.

In vitro and in vivo properties of ellagic acid in malaria treatment.

Soh PN, Witkowski B, Olagnier D, Nicolau ML, Garcia-Alvarez MC, Berry A, Benoit-Vical F.

Antimicrob Agents Chemother. 2009 Mar;53(3):1100-6. doi: 10.1128/AAC.01175-08. Epub 2008 Nov 17.

7.
8.

Small molecule inhibition of apicomplexan FtsH1 disrupts plastid biogenesis in human pathogens.

Amberg-Johnson K, Hari SB, Ganesan SM, Lorenzi HA, Sauer RT, Niles JC, Yeh E.

Elife. 2017 Aug 18;6. pii: e29865. doi: 10.7554/eLife.29865.

9.

Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.

Skinner-Adams TS, Andrews KT, Melville L, McCarthy J, Gardiner DL.

Antimicrob Agents Chemother. 2007 Feb;51(2):759-62. Epub 2006 Nov 6.

10.

Inhibition of Toxoplasma gondii and Plasmodium falciparum infections in vitro by NSC3852, a redox active antiproliferative and tumor cell differentiation agent.

Strobl JS, Seibert CW, Li Y, Nagarkatti R, Mitchell SM, Rosypal AC, Rathore D, Lindsay DS.

J Parasitol. 2009 Feb;95(1):215-23. doi: 10.1645/GE-1608.1.

PMID:
18837587
11.

The fate of ferriprotorphyrin IX in malaria infected erythrocytes in conjunction with the mode of action of antimalarial drugs.

Zhang J, Krugliak M, Ginsburg H.

Mol Biochem Parasitol. 1999 Mar 15;99(1):129-41.

PMID:
10215030
12.

A novel flow cytometric hemozoin detection assay for real-time sensitivity testing of Plasmodium falciparum.

Rebelo M, Sousa C, Shapiro HM, Mota MM, Grobusch MP, Hänscheid T.

PLoS One. 2013 Apr 24;8(4):e61606. doi: 10.1371/journal.pone.0061606. Print 2013.

13.

Targeted Phenotypic Screening in Plasmodium falciparum and Toxoplasma gondii Reveals Novel Modes of Action of Medicines for Malaria Venture Malaria Box Molecules.

Subramanian G, Belekar MA, Shukla A, Tong JX, Sinha A, Chu TTT, Kulkarni AS, Preiser PR, Reddy DS, Tan KSW, Shanmugam D, Chandramohanadas R.

mSphere. 2018 Jan 17;3(1). pii: e00534-17. doi: 10.1128/mSphere.00534-17. eCollection 2018 Jan-Feb. Erratum in: mSphere. 2019 Mar 13;4(2):.

14.

In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar.

Randrianarivelojosia M, Ratsimbasoa A, Randrianasolo L, Randrianarijaona A, Jambou R.

East Afr Med J. 2002 May;79(5):237-41.

PMID:
12638806
15.

Complex polymorphisms in the Plasmodium falciparum multidrug resistance protein 2 gene and its contribution to antimalarial response.

Veiga MI, Osório NS, Ferreira PE, Franzén O, Dahlstrom S, Lum JK, Nosten F, Gil JP.

Antimicrob Agents Chemother. 2014 Dec;58(12):7390-7. doi: 10.1128/AAC.03337-14. Epub 2014 Sep 29.

16.

Roxithromycin potentiates the effects of chloroquine and mefloquine on multidrug-resistant Plasmodium falciparum in vitro.

Min TH, Khairul MF, Low JH, Che Nasriyyah CH, A'shikin AN, Norazmi MN, Ravichandran M, Raju SS.

Exp Parasitol. 2007 Apr;115(4):387-92. Epub 2006 Nov 21.

PMID:
17118354
17.
18.

Defining the timing of action of antimalarial drugs against Plasmodium falciparum.

Wilson DW, Langer C, Goodman CD, McFadden GI, Beeson JG.

Antimicrob Agents Chemother. 2013 Mar;57(3):1455-67. doi: 10.1128/AAC.01881-12. Epub 2013 Jan 14.

19.

Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate.

de Pilla Varotti F, Botelho AC, Andrade AA, de Paula RC, Fagundes EM, Valverde A, Mayer LM, Mendonça JS, de Souza MV, Boechat N, Krettli AU.

Antimicrob Agents Chemother. 2008 Nov;52(11):3868-74. doi: 10.1128/AAC.00510-08. Epub 2008 Aug 18.

20.

Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.

Wurtz N, Fall B, Pascual A, Fall M, Baret E, Camara C, Nakoulima A, Diatta B, Fall KB, Mbaye PS, Diémé Y, Bercion R, Wade B, Pradines B.

Antimicrob Agents Chemother. 2014 Dec;58(12):7032-40. doi: 10.1128/AAC.03494-14. Epub 2014 Sep 8.

Supplemental Content

Support Center